543500 — Evoq Remedies Balance Sheet
0.000.00%
- IN₹88.64m
- IN₹85.57m
- IN₹117.57m
- 40
- 90
- 24
- 51
Annual balance sheet for Evoq Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.333 | 30.9 | 1.54 | 1.23 | 2.14 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 77.1 | 291 | 251 | 333 | 365 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 80.5 | 333 | 349 | 368 | 498 |
| Net Property, Plant And Equipment | 0 | 0 | 0.093 | 0.14 | 2.23 |
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 80.5 | 333 | 349 | 369 | 500 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 73 | 102 | 101 | 116 | 54.7 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 73 | 102 | 101 | 116 | 54.7 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 7.43 | 232 | 248 | 252 | 445 |
| Total Liabilities & Shareholders' Equity | 80.5 | 333 | 349 | 369 | 500 |
| Total Common Shares Outstanding |